|
|
|
NSPH - Nanosphere, Inc.
Nanosphere, Inc. (NSPH) was a biotechnology company that developed molecular diagnostic tests for infectious diseases and other conditions. However, it's important to note that Nanosphere, Inc. is no longer an active publicly traded company.
The company was acquired by Luminex Corporation in 2016. At the time of the acquisition, the market capitalization of Nanosphere, Inc. was approximately $77 million.
Prior to the acquisition, Nanosphere, Inc. developed a number of diagnostic tests based on its proprietary Verigene platform. The platform used nucleic acid detection technology to provide rapid and accurate diagnoses for a range of infectious diseases and other conditions.
Overall, while Nanosphere, Inc. is no longer an active publicly traded company, its legacy can be seen in the continued importance of molecular diagnostic technologies and the ongoing development of innovative solutions for infectious disease testing and other applications.
|
|
|
|
|
